Company research
Aurinia Pharmaceuticals Inc.
CIK 1600620Updated Sep 24, 2026
SecurityAUPH · NASDAQ · equity
AUPH price & chart
Loading TradingView…
NASDAQ:AUPH on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
SCHEDULE 13D/A filing
144 filing
Other Events
Items 8.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 751,587,000Source | 550,645,000Source | 548,062,000Source | 470,860,000Source |
| Property, Plant and Equipment, NetUSD | 2,111,000Source | 2,731,000Source | 3,354,000Source | 3,650,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 80,160,000Source | 83,396,000Source | 48,755,000Source | 94,088,000Source |
| Inventory, NetUSD | 45,690,000Source | 39,228,000Source | 39,705,000Source | 24,752,000Source |
| Assets, CurrentUSD | 491,967,000Source | 446,596,000Source | 424,800,000Source | 442,539,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,596,000Source | 4,068,000Source | 4,498,000Source | 4,907,000Source |
| Other Assets, NoncurrentUSD | 93,000Source | 823,000Source | 1,517,000Source | 13,339,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 170,256,000Source | 173,167,000Source | 170,108,000Source | 65,425,000Source |
| Stockholders’ equity: | ||||
| Retained Earnings (Accumulated Deficit)USD | -649,368,000Source | -936,570,000Source | -942,322,000Source | -864,302,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -599,000Source | -647,000Source | -730,000Source | -1,061,000Source |
| Stockholders' Equity Attributable to ParentUSD | 581,331,000Source | 377,478,000Source | 377,954,000Source | 405,435,000Source |
| Additional Paid in Capital, Common StockUSD | 111,263,000Source | 126,999,000Source | 120,788,000Source | 85,489,000Source |
| Liabilities and EquityUSD | 751,587,000Source | 550,645,000Source | 548,062,000Source | 470,860,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 93,724,000Source | 97,763,000Source | 77,188,000Source | 46,107,000Source |
| Operating Lease, Liability, CurrentUSD | 1,067,000Source | 1,026,000Source | 989,000Source | 936,000Source |
| Accounts Payable, CurrentUSD | 3,313,000Source | 5,187,000Source | — | — |
| Operating Lease, Liability, NoncurrentUSD | 4,900,000Source | 5,743,000Source | 6,530,000Source | 7,152,000Source |
| Other Liabilities, NoncurrentUSD | 6,700,000Source | 11,107,000Source | 10,911,000Source | 12,166,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 66,621,000Source | 64,971,000Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 19,449,000Source | 19,445,000Source | 11,647,000Source | 2,706,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 14,678,000Source | 31,596,000Source | 45,311,000Source | 32,300,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 6,462,000Source | -477,000Source | 15,869,000Source | 9,072,000Source |
| Increase (Decrease) in Accounts PayableUSD | -1,874,000Source | 860,000Source | — | — |
| Deferred Income Tax Expense (Benefit)USD | -176,194,000Source | — | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 135,658,000Source | 44,388,000Source | -33,461,000Source | -79,529,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -32,768,000Source | 39,262,000Source | -6,706,000Source | -60,632,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 9,764,000Source | 6,134,000Source | — | — |
| Payments for Repurchase of Common StockUSD | 98,156,000Source | 40,239,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -106,110,000Source | -49,092,000Source | -5,130,000Source | 2,433,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -3,220,000Source | 34,558,000Source | -45,297,000Source | -137,728,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 80,213,000Source | 83,433,000Source | 48,875,000Source | 94,172,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 2,816,000Source | 2,184,000Source | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 14,678,000Source | 31,596,000Source | 45,311,000Source | 32,300,000Source |
| Amortization of Intangible AssetsUSD | 800,000Source | 900,000Source | 1,700,000Source | 2,100,000Source |
| DepreciationUSD | 600,000Source | 600,000Source | 606,000Source | 629,000Source |
| General and Administrative ExpenseUSD | 101,794,000Source | 172,028,000Source | 195,036,000Source | 196,371,000Source |
| Income Tax Expense (Benefit)USD | -173,045,000Source | 1,696,000Source | 551,000Source | 1,828,000Source |
| InterestExpenseNonoperatingUSD | 4,330,000Source | 4,835,000Source | — | — |
| Inventory Write-downUSD | 0Source | 0Source | 916,000Source | 3,646,000Source |
| Investment Income, InterestUSD | 13,573,000Source | 16,970,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | 287,202,000Source | 5,752,000Source | -78,020,000Source | -108,180,000Source |
| Operating ExpensesUSD | 178,141,000Source | 239,820,000Source | — | — |
| Other Operating Income (Expense), NetUSD | -9,530,000Source | 4,347,000Source | -8,379,000Source | 1,523,000Source |
| Proceeds from Issuance of Common StockUSD | 756,000Source | 1,084,000Source | 0Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | 14,190,000Source | 8,186,000Source | 4,895,000Source | 2,433,000Source |
| Restructuring CostsUSD | 1,647,000Source | 23,106,000Source | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 283,055,000Source | 235,133,000Source | 175,513,000Source | 134,030,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 195,000,000Source | 196,400,000Source |
| Operating Income (Loss)USD | 104,914,000Source | -4,687,000Source | -91,691,000Source | -111,470,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 114,157,000Source | 7,448,000Source | -77,469,000Source | -106,352,000Source |
| Income Tax Expense (Benefit)USD | -173,045,000Source | 1,696,000Source | 551,000Source | 1,828,000Source |
| Net Income (Loss) Attributable to ParentUSD | 287,202,000Source | 5,752,000Source | -78,020,000Source | -108,180,000Source |
| Earnings Per Share, BasicUSD per share | 2.14Source | 0.04Source | -0.54Source | -0.76Source |
| Earnings Per Share, DilutedUSD per share | 2.07Source | 0.04Source | -0.54Source | -0.76Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 134,367,000Source | 143,057,000Source | 143,236,000Source | 141,915,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 138,700,000Source | 146,194,000Source | 143,236,000Source | 141,915,000Source |
| Interest Expense (non-operating)USD | 4,330,000Source | 4,835,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 800,000Source | 900,000Source | 1,700,000Source | 2,100,000Source |
| Costs and ExpensesUSD | 178,141,000Source | 239,820,000Source | 267,204,000Source | 245,500,000Source |
| Current Income Tax Expense (Benefit)USD | 3,149,000Source | — | 551,000Source | 1,828,000Source |
| General and Administrative ExpenseUSD | 101,794,000Source | 172,028,000Source | 195,036,000Source | 196,371,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 103,909,000Source | -8,416,000Source | -90,226,000Source | -112,359,000Source |
| Interest ExpenseUSD | — | — | 2,775,000Source | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | 16,997,000Source | 5,118,000Source |
| Investment Income, InterestUSD | 13,573,000Source | 16,970,000Source | — | — |
| Operating ExpensesUSD | 178,141,000Source | 239,820,000Source | — | — |
| Other Operating Income (Expense), NetUSD | -9,530,000Source | 4,347,000Source | -8,379,000Source | 1,523,000Source |
| Research and Development ExpenseUSD | 32,505,000Source | 20,785,000Source | 49,641,000Source | 44,988,000Source |
| Restructuring CostsUSD | 1,647,000Source | 23,106,000Source | — | — |